aluates Reports

$ 0.0

Automative

Global Viral Vector CDMO Services Market Research Report 2025

Published Date: 2025-05-06

Report Code: QYRE-Auto-18U16299

Global Viral Vector CDMO Services Market Research Report 2023

BUY CHAPTERS

Global Viral Vector CDMO Services Market Research Report 2025

Code: QYRE-Auto-18U16299

Report

2025-05-06

Pages:135

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Viral Vector CDMO Services Market

The global market for Viral Vector CDMO Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Viral Vector CDMO Services refers to contract development and manufacturing organizations (CDMOs) that provide custom production and development services for viral vectors. Viral vectors are a commonly used gene therapy tool that deliver target genes into human cells to treat disease. Viral Vector CDMO Services provides various types of viral vector production services, including adenovirus vectors, AAV vectors, and LV vectors.

CDMO companies usually provide a full range of viral vector production and development services from the research stage to commercial production, including quality control, preparation, analysis, packaging and storage services. These services help accelerate the development and commercialization of gene therapy drugs and advance the field of gene therapy.

CDMO companies can also help customers develop production plans that suit their product needs, and provide customized technical support and solutions based on customer needs. Customers can choose the appropriate CDMO company as a partner based on their needs to ensure the high-quality production and successful launch of their gene therapy products.

North American market for Viral Vector CDMO Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Viral Vector CDMO Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Viral Vector CDMO Services in Vaccine Development is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Viral Vector CDMO Services include Thermo Fisher Scientific, Lonza, Catalent, Charles River, Merck, SK pharmteco, Oxford Biomedica, AGC Biologics（MolMed）, Gene Universal, Polyplus (Sartorius), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Viral Vector CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector CDMO Services.

The Viral Vector CDMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Viral Vector CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Viral Vector CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Viral Vector CDMO Services Market Report

Report Metric	Details
Report Name	Viral Vector CDMO Services Market
Segment by Type	AAV Lentivirus Adenovirus HSV Others
Segment by Application	Vaccine Development Gene Therapy Academic Scientific Research Institution Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, Lonza, Catalent, Charles River, Merck, SK pharmteco, Oxford Biomedica, AGC Biologics（MolMed）, Gene Universal, Polyplus (Sartorius), CCRM, FUJIFILM Diosynth Biotechnologies, Biovian, Miltenyi Bioindustry, Aldevron, Takara Bio, Yposkesi, Genezen, GenScript ProBio, EurekaBio, Obio Technology, GeneSail Biotech, VectorBuilder, WuXi ATU, Ubrigene, Porton Biologics, Pharmaron, PackGene Biotechnology, Hillgene, Asymchem, Exthera, Flash Therapeutics, VIVEBiotech, FinVector, uBriGene, Eurogentec, VGXI
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Vector CDMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Viral Vector CDMO Services Market report?

Ans: The main players in the Viral Vector CDMO Services Market are Thermo Fisher Scientific, Lonza, Catalent, Charles River, Merck, SK pharmteco, Oxford Biomedica, AGC Biologics（MolMed）, Gene Universal, Polyplus (Sartorius), CCRM, FUJIFILM Diosynth Biotechnologies, Biovian, Miltenyi Bioindustry, Aldevron, Takara Bio, Yposkesi, Genezen, GenScript ProBio, EurekaBio, Obio Technology, GeneSail Biotech, VectorBuilder, WuXi ATU, Ubrigene, Porton Biologics, Pharmaron, PackGene Biotechnology, Hillgene, Asymchem, Exthera, Flash Therapeutics, VIVEBiotech, FinVector, uBriGene, Eurogentec, VGXI

What are the Application segmentation covered in the Viral Vector CDMO Services Market report?

Ans: The Applications covered in the Viral Vector CDMO Services Market report are Vaccine Development, Gene Therapy, Academic Scientific Research Institution, Others

What are the Type segmentation covered in the Viral Vector CDMO Services Market report?

Ans: The Types covered in the Viral Vector CDMO Services Market report are AAV, Lentivirus, Adenovirus, HSV, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Viral Vector CDMO Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 AAV

1.2.3 Lentivirus

1.2.4 Adenovirus

1.2.5 HSV

1.2.6 Others

1.3 Market by Application

1.3.1 Global Viral Vector CDMO Services Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Vaccine Development

1.3.3 Gene Therapy

1.3.4 Academic Scientific Research Institution

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Viral Vector CDMO Services Market Perspective (2020-2031)

2.2 Global Viral Vector CDMO Services Growth Trends by Region

2.2.1 Global Viral Vector CDMO Services Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Viral Vector CDMO Services Historic Market Size by Region (2020-2025)

2.2.3 Viral Vector CDMO Services Forecasted Market Size by Region (2026-2031)

2.3 Viral Vector CDMO Services Market Dynamics

2.3.1 Viral Vector CDMO Services Industry Trends

2.3.2 Viral Vector CDMO Services Market Drivers

2.3.3 Viral Vector CDMO Services Market Challenges

2.3.4 Viral Vector CDMO Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Viral Vector CDMO Services Players by Revenue

3.1.1 Global Top Viral Vector CDMO Services Players by Revenue (2020-2025)

3.1.2 Global Viral Vector CDMO Services Revenue Market Share by Players (2020-2025)

3.2 Global Viral Vector CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Viral Vector CDMO Services Revenue

3.4 Global Viral Vector CDMO Services Market Concentration Ratio

3.4.1 Global Viral Vector CDMO Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Viral Vector CDMO Services Revenue in 2024

3.5 Global Key Players of Viral Vector CDMO Services Head office and Area Served

3.6 Global Key Players of Viral Vector CDMO Services, Product and Application

3.7 Global Key Players of Viral Vector CDMO Services, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Viral Vector CDMO Services Breakdown Data by Type

4.1 Global Viral Vector CDMO Services Historic Market Size by Type (2020-2025)

4.2 Global Viral Vector CDMO Services Forecasted Market Size by Type (2026-2031)

5 Viral Vector CDMO Services Breakdown Data by Application

5.1 Global Viral Vector CDMO Services Historic Market Size by Application (2020-2025)

5.2 Global Viral Vector CDMO Services Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Viral Vector CDMO Services Market Size (2020-2031)

6.2 North America Viral Vector CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Viral Vector CDMO Services Market Size by Country (2020-2025)

6.4 North America Viral Vector CDMO Services Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Viral Vector CDMO Services Market Size (2020-2031)

7.2 Europe Viral Vector CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Viral Vector CDMO Services Market Size by Country (2020-2025)

7.4 Europe Viral Vector CDMO Services Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Viral Vector CDMO Services Market Size (2020-2031)

8.2 Asia-Pacific Viral Vector CDMO Services Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Viral Vector CDMO Services Market Size by Region (2020-2025)

8.4 Asia-Pacific Viral Vector CDMO Services Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Viral Vector CDMO Services Market Size (2020-2031)

9.2 Latin America Viral Vector CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Viral Vector CDMO Services Market Size by Country (2020-2025)

9.4 Latin America Viral Vector CDMO Services Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Viral Vector CDMO Services Market Size (2020-2031)

10.2 Middle East & Africa Viral Vector CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Viral Vector CDMO Services Market Size by Country (2020-2025)

10.4 Middle East & Africa Viral Vector CDMO Services Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Viral Vector CDMO Services Introduction

11.1.4 Thermo Fisher Scientific Revenue in Viral Vector CDMO Services Business (2020-2025)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Lonza

11.2.1 Lonza Company Details

11.2.2 Lonza Business Overview

11.2.3 Lonza Viral Vector CDMO Services Introduction

11.2.4 Lonza Revenue in Viral Vector CDMO Services Business (2020-2025)

11.2.5 Lonza Recent Development

11.3 Catalent

11.3.1 Catalent Company Details

11.3.2 Catalent Business Overview

11.3.3 Catalent Viral Vector CDMO Services Introduction

11.3.4 Catalent Revenue in Viral Vector CDMO Services Business (2020-2025)

11.3.5 Catalent Recent Development

11.4 Charles River

11.4.1 Charles River Company Details

11.4.2 Charles River Business Overview

11.4.3 Charles River Viral Vector CDMO Services Introduction

11.4.4 Charles River Revenue in Viral Vector CDMO Services Business (2020-2025)

11.4.5 Charles River Recent Development

11.5 Merck

11.5.1 Merck Company Details

11.5.2 Merck Business Overview

11.5.3 Merck Viral Vector CDMO Services Introduction

11.5.4 Merck Revenue in Viral Vector CDMO Services Business (2020-2025)

11.5.5 Merck Recent Development

11.6 SK pharmteco

11.6.1 SK pharmteco Company Details

11.6.2 SK pharmteco Business Overview

11.6.3 SK pharmteco Viral Vector CDMO Services Introduction

11.6.4 SK pharmteco Revenue in Viral Vector CDMO Services Business (2020-2025)

11.6.5 SK pharmteco Recent Development

11.7 Oxford Biomedica

11.7.1 Oxford Biomedica Company Details

11.7.2 Oxford Biomedica Business Overview

11.7.3 Oxford Biomedica Viral Vector CDMO Services Introduction

11.7.4 Oxford Biomedica Revenue in Viral Vector CDMO Services Business (2020-2025)

11.7.5 Oxford Biomedica Recent Development

11.8 AGC Biologics（MolMed）

11.8.1 AGC Biologics（MolMed） Company Details

11.8.2 AGC Biologics（MolMed） Business Overview

11.8.3 AGC Biologics（MolMed） Viral Vector CDMO Services Introduction

11.8.4 AGC Biologics（MolMed） Revenue in Viral Vector CDMO Services Business (2020-2025)

11.8.5 AGC Biologics（MolMed） Recent Development

11.9 Gene Universal

11.9.1 Gene Universal Company Details

11.9.2 Gene Universal Business Overview

11.9.3 Gene Universal Viral Vector CDMO Services Introduction

11.9.4 Gene Universal Revenue in Viral Vector CDMO Services Business (2020-2025)

11.9.5 Gene Universal Recent Development

11.10 Polyplus (Sartorius)

11.10.1 Polyplus (Sartorius) Company Details

11.10.2 Polyplus (Sartorius) Business Overview

11.10.3 Polyplus (Sartorius) Viral Vector CDMO Services Introduction

11.10.4 Polyplus (Sartorius) Revenue in Viral Vector CDMO Services Business (2020-2025)

11.10.5 Polyplus (Sartorius) Recent Development

11.11 CCRM

11.11.1 CCRM Company Details

11.11.2 CCRM Business Overview

11.11.3 CCRM Viral Vector CDMO Services Introduction

11.11.4 CCRM Revenue in Viral Vector CDMO Services Business (2020-2025)

11.11.5 CCRM Recent Development

11.12 FUJIFILM Diosynth Biotechnologies

11.12.1 FUJIFILM Diosynth Biotechnologies Company Details

11.12.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.12.3 FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Introduction

11.12.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector CDMO Services Business (2020-2025)

11.12.5 FUJIFILM Diosynth Biotechnologies Recent Development

11.13 Biovian

11.13.1 Biovian Company Details

11.13.2 Biovian Business Overview

11.13.3 Biovian Viral Vector CDMO Services Introduction

11.13.4 Biovian Revenue in Viral Vector CDMO Services Business (2020-2025)

11.13.5 Biovian Recent Development

11.14 Miltenyi Bioindustry

11.14.1 Miltenyi Bioindustry Company Details

11.14.2 Miltenyi Bioindustry Business Overview

11.14.3 Miltenyi Bioindustry Viral Vector CDMO Services Introduction

11.14.4 Miltenyi Bioindustry Revenue in Viral Vector CDMO Services Business (2020-2025)

11.14.5 Miltenyi Bioindustry Recent Development

11.15 Aldevron

11.15.1 Aldevron Company Details

11.15.2 Aldevron Business Overview

11.15.3 Aldevron Viral Vector CDMO Services Introduction

11.15.4 Aldevron Revenue in Viral Vector CDMO Services Business (2020-2025)

11.15.5 Aldevron Recent Development

11.16 Takara Bio

11.16.1 Takara Bio Company Details

11.16.2 Takara Bio Business Overview

11.16.3 Takara Bio Viral Vector CDMO Services Introduction

11.16.4 Takara Bio Revenue in Viral Vector CDMO Services Business (2020-2025)

11.16.5 Takara Bio Recent Development

11.17 Yposkesi

11.17.1 Yposkesi Company Details

11.17.2 Yposkesi Business Overview

11.17.3 Yposkesi Viral Vector CDMO Services Introduction

11.17.4 Yposkesi Revenue in Viral Vector CDMO Services Business (2020-2025)

11.17.5 Yposkesi Recent Development

11.18 Genezen

11.18.1 Genezen Company Details

11.18.2 Genezen Business Overview

11.18.3 Genezen Viral Vector CDMO Services Introduction

11.18.4 Genezen Revenue in Viral Vector CDMO Services Business (2020-2025)

11.18.5 Genezen Recent Development

11.19 GenScript ProBio

11.19.1 GenScript ProBio Company Details

11.19.2 GenScript ProBio Business Overview

11.19.3 GenScript ProBio Viral Vector CDMO Services Introduction

11.19.4 GenScript ProBio Revenue in Viral Vector CDMO Services Business (2020-2025)

11.19.5 GenScript ProBio Recent Development

11.20 EurekaBio

11.20.1 EurekaBio Company Details

11.20.2 EurekaBio Business Overview

11.20.3 EurekaBio Viral Vector CDMO Services Introduction

11.20.4 EurekaBio Revenue in Viral Vector CDMO Services Business (2020-2025)

11.20.5 EurekaBio Recent Development

11.21 Obio Technology

11.21.1 Obio Technology Company Details

11.21.2 Obio Technology Business Overview

11.21.3 Obio Technology Viral Vector CDMO Services Introduction

11.21.4 Obio Technology Revenue in Viral Vector CDMO Services Business (2020-2025)

11.21.5 Obio Technology Recent Development

11.22 GeneSail Biotech

11.22.1 GeneSail Biotech Company Details

11.22.2 GeneSail Biotech Business Overview

11.22.3 GeneSail Biotech Viral Vector CDMO Services Introduction

11.22.4 GeneSail Biotech Revenue in Viral Vector CDMO Services Business (2020-2025)

11.22.5 GeneSail Biotech Recent Development

11.23 VectorBuilder

11.23.1 VectorBuilder Company Details

11.23.2 VectorBuilder Business Overview

11.23.3 VectorBuilder Viral Vector CDMO Services Introduction

11.23.4 VectorBuilder Revenue in Viral Vector CDMO Services Business (2020-2025)

11.23.5 VectorBuilder Recent Development

11.24 WuXi ATU

11.24.1 WuXi ATU Company Details

11.24.2 WuXi ATU Business Overview

11.24.3 WuXi ATU Viral Vector CDMO Services Introduction

11.24.4 WuXi ATU Revenue in Viral Vector CDMO Services Business (2020-2025)

11.24.5 WuXi ATU Recent Development

11.25 Ubrigene

11.25.1 Ubrigene Company Details

11.25.2 Ubrigene Business Overview

11.25.3 Ubrigene Viral Vector CDMO Services Introduction

11.25.4 Ubrigene Revenue in Viral Vector CDMO Services Business (2020-2025)

11.25.5 Ubrigene Recent Development

11.26 Porton Biologics

11.26.1 Porton Biologics Company Details

11.26.2 Porton Biologics Business Overview

11.26.3 Porton Biologics Viral Vector CDMO Services Introduction

11.26.4 Porton Biologics Revenue in Viral Vector CDMO Services Business (2020-2025)

11.26.5 Porton Biologics Recent Development

11.27 Pharmaron

11.27.1 Pharmaron Company Details

11.27.2 Pharmaron Business Overview

11.27.3 Pharmaron Viral Vector CDMO Services Introduction

11.27.4 Pharmaron Revenue in Viral Vector CDMO Services Business (2020-2025)

11.27.5 Pharmaron Recent Development

11.28 PackGene Biotechnology

11.28.1 PackGene Biotechnology Company Details

11.28.2 PackGene Biotechnology Business Overview

11.28.3 PackGene Biotechnology Viral Vector CDMO Services Introduction

11.28.4 PackGene Biotechnology Revenue in Viral Vector CDMO Services Business (2020-2025)

11.28.5 PackGene Biotechnology Recent Development

11.29 Hillgene

11.29.1 Hillgene Company Details

11.29.2 Hillgene Business Overview

11.29.3 Hillgene Viral Vector CDMO Services Introduction

11.29.4 Hillgene Revenue in Viral Vector CDMO Services Business (2020-2025)

11.29.5 Hillgene Recent Development

11.30 Asymchem

11.30.1 Asymchem Company Details

11.30.2 Asymchem Business Overview

11.30.3 Asymchem Viral Vector CDMO Services Introduction

11.30.4 Asymchem Revenue in Viral Vector CDMO Services Business (2020-2025)

11.30.5 Asymchem Recent Development

11.31 Exthera

11.31.1 Exthera Company Details

11.31.2 Exthera Business Overview

11.31.3 Exthera Viral Vector CDMO Services Introduction

11.31.4 Exthera Revenue in Viral Vector CDMO Services Business (2020-2025)

11.31.5 Exthera Recent Development

11.32 Flash Therapeutics

11.32.1 Flash Therapeutics Company Details

11.32.2 Flash Therapeutics Business Overview

11.32.3 Flash Therapeutics Viral Vector CDMO Services Introduction

11.32.4 Flash Therapeutics Revenue in Viral Vector CDMO Services Business (2020-2025)

11.32.5 Flash Therapeutics Recent Development

11.33 VIVEBiotech

11.33.1 VIVEBiotech Company Details

11.33.2 VIVEBiotech Business Overview

11.33.3 VIVEBiotech Viral Vector CDMO Services Introduction

11.33.4 VIVEBiotech Revenue in Viral Vector CDMO Services Business (2020-2025)

11.33.5 VIVEBiotech Recent Development

11.34 FinVector

11.34.1 FinVector Company Details

11.34.2 FinVector Business Overview

11.34.3 FinVector Viral Vector CDMO Services Introduction

11.34.4 FinVector Revenue in Viral Vector CDMO Services Business (2020-2025)

11.34.5 FinVector Recent Development

11.35 uBriGene

11.35.1 uBriGene Company Details

11.35.2 uBriGene Business Overview

11.35.3 uBriGene Viral Vector CDMO Services Introduction

11.35.4 uBriGene Revenue in Viral Vector CDMO Services Business (2020-2025)

11.35.5 uBriGene Recent Development

11.36 Eurogentec

11.36.1 Eurogentec Company Details

11.36.2 Eurogentec Business Overview

11.36.3 Eurogentec Viral Vector CDMO Services Introduction

11.36.4 Eurogentec Revenue in Viral Vector CDMO Services Business (2020-2025)

11.36.5 Eurogentec Recent Development

11.37 VGXI

11.37.1 VGXI Company Details

11.37.2 VGXI Business Overview

11.37.3 VGXI Viral Vector CDMO Services Introduction

11.37.4 VGXI Revenue in Viral Vector CDMO Services Business (2020-2025)

11.37.5 VGXI Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global Viral Vector CDMO Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of AAV

Table 3. Key Players of Lentivirus

Table 4. Key Players of Adenovirus

Table 5. Key Players of HSV

Table 6. Key Players of Others

Table 7. Global Viral Vector CDMO Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Viral Vector CDMO Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Viral Vector CDMO Services Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Viral Vector CDMO Services Market Share by Region (2020-2025)

Table 11. Global Viral Vector CDMO Services Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Viral Vector CDMO Services Market Share by Region (2026-2031)

Table 13. Viral Vector CDMO Services Market Trends

Table 14. Viral Vector CDMO Services Market Drivers

Table 15. Viral Vector CDMO Services Market Challenges

Table 16. Viral Vector CDMO Services Market Restraints

Table 17. Global Viral Vector CDMO Services Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Viral Vector CDMO Services Market Share by Players (2020-2025)

Table 19. Global Top Viral Vector CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector CDMO Services as of 2024)

Table 20. Ranking of Global Top Viral Vector CDMO Services Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Viral Vector CDMO Services Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Viral Vector CDMO Services, Headquarters and Area Served

Table 23. Global Key Players of Viral Vector CDMO Services, Product and Application

Table 24. Global Key Players of Viral Vector CDMO Services, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Viral Vector CDMO Services Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Viral Vector CDMO Services Revenue Market Share by Type (2020-2025)

Table 28. Global Viral Vector CDMO Services Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Viral Vector CDMO Services Revenue Market Share by Type (2026-2031)

Table 30. Global Viral Vector CDMO Services Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Viral Vector CDMO Services Revenue Market Share by Application (2020-2025)

Table 32. Global Viral Vector CDMO Services Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Viral Vector CDMO Services Revenue Market Share by Application (2026-2031)

Table 34. North America Viral Vector CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Viral Vector CDMO Services Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Viral Vector CDMO Services Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Viral Vector CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Viral Vector CDMO Services Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Viral Vector CDMO Services Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Viral Vector CDMO Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Viral Vector CDMO Services Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Viral Vector CDMO Services Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Viral Vector CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Viral Vector CDMO Services Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Viral Vector CDMO Services Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Viral Vector CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Viral Vector CDMO Services Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Viral Vector CDMO Services Market Size by Country (2026-2031) & (US$ Million)

Table 49. Thermo Fisher Scientific Company Details

Table 50. Thermo Fisher Scientific Business Overview

Table 51. Thermo Fisher Scientific Viral Vector CDMO Services Product

Table 52. Thermo Fisher Scientific Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 53. Thermo Fisher Scientific Recent Development

Table 54. Lonza Company Details

Table 55. Lonza Business Overview

Table 56. Lonza Viral Vector CDMO Services Product

Table 57. Lonza Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 58. Lonza Recent Development

Table 59. Catalent Company Details

Table 60. Catalent Business Overview

Table 61. Catalent Viral Vector CDMO Services Product

Table 62. Catalent Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 63. Catalent Recent Development

Table 64. Charles River Company Details

Table 65. Charles River Business Overview

Table 66. Charles River Viral Vector CDMO Services Product

Table 67. Charles River Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 68. Charles River Recent Development

Table 69. Merck Company Details

Table 70. Merck Business Overview

Table 71. Merck Viral Vector CDMO Services Product

Table 72. Merck Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 73. Merck Recent Development

Table 74. SK pharmteco Company Details

Table 75. SK pharmteco Business Overview

Table 76. SK pharmteco Viral Vector CDMO Services Product

Table 77. SK pharmteco Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 78. SK pharmteco Recent Development

Table 79. Oxford Biomedica Company Details

Table 80. Oxford Biomedica Business Overview

Table 81. Oxford Biomedica Viral Vector CDMO Services Product

Table 82. Oxford Biomedica Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 83. Oxford Biomedica Recent Development

Table 84. AGC Biologics（MolMed） Company Details

Table 85. AGC Biologics（MolMed） Business Overview

Table 86. AGC Biologics（MolMed） Viral Vector CDMO Services Product

Table 87. AGC Biologics（MolMed） Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 88. AGC Biologics（MolMed） Recent Development

Table 89. Gene Universal Company Details

Table 90. Gene Universal Business Overview

Table 91. Gene Universal Viral Vector CDMO Services Product

Table 92. Gene Universal Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 93. Gene Universal Recent Development

Table 94. Polyplus (Sartorius) Company Details

Table 95. Polyplus (Sartorius) Business Overview

Table 96. Polyplus (Sartorius) Viral Vector CDMO Services Product

Table 97. Polyplus (Sartorius) Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 98. Polyplus (Sartorius) Recent Development

Table 99. CCRM Company Details

Table 100. CCRM Business Overview

Table 101. CCRM Viral Vector CDMO Services Product

Table 102. CCRM Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 103. CCRM Recent Development

Table 104. FUJIFILM Diosynth Biotechnologies Company Details

Table 105. FUJIFILM Diosynth Biotechnologies Business Overview

Table 106. FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Product

Table 107. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 108. FUJIFILM Diosynth Biotechnologies Recent Development

Table 109. Biovian Company Details

Table 110. Biovian Business Overview

Table 111. Biovian Viral Vector CDMO Services Product

Table 112. Biovian Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 113. Biovian Recent Development

Table 114. Miltenyi Bioindustry Company Details

Table 115. Miltenyi Bioindustry Business Overview

Table 116. Miltenyi Bioindustry Viral Vector CDMO Services Product

Table 117. Miltenyi Bioindustry Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 118. Miltenyi Bioindustry Recent Development

Table 119. Aldevron Company Details

Table 120. Aldevron Business Overview

Table 121. Aldevron Viral Vector CDMO Services Product

Table 122. Aldevron Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 123. Aldevron Recent Development

Table 124. Takara Bio Company Details

Table 125. Takara Bio Business Overview

Table 126. Takara Bio Viral Vector CDMO Services Product

Table 127. Takara Bio Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 128. Takara Bio Recent Development

Table 129. Yposkesi Company Details

Table 130. Yposkesi Business Overview

Table 131. Yposkesi Viral Vector CDMO Services Product

Table 132. Yposkesi Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 133. Yposkesi Recent Development

Table 134. Genezen Company Details

Table 135. Genezen Business Overview

Table 136. Genezen Viral Vector CDMO Services Product

Table 137. Genezen Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 138. Genezen Recent Development

Table 139. GenScript ProBio Company Details

Table 140. GenScript ProBio Business Overview

Table 141. GenScript ProBio Viral Vector CDMO Services Product

Table 142. GenScript ProBio Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 143. GenScript ProBio Recent Development

Table 144. EurekaBio Company Details

Table 145. EurekaBio Business Overview

Table 146. EurekaBio Viral Vector CDMO Services Product

Table 147. EurekaBio Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 148. EurekaBio Recent Development

Table 149. Obio Technology Company Details

Table 150. Obio Technology Business Overview

Table 151. Obio Technology Viral Vector CDMO Services Product

Table 152. Obio Technology Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 153. Obio Technology Recent Development

Table 154. GeneSail Biotech Company Details

Table 155. GeneSail Biotech Business Overview

Table 156. GeneSail Biotech Viral Vector CDMO Services Product

Table 157. GeneSail Biotech Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 158. GeneSail Biotech Recent Development

Table 159. VectorBuilder Company Details

Table 160. VectorBuilder Business Overview

Table 161. VectorBuilder Viral Vector CDMO Services Product

Table 162. VectorBuilder Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 163. VectorBuilder Recent Development

Table 164. WuXi ATU Company Details

Table 165. WuXi ATU Business Overview

Table 166. WuXi ATU Viral Vector CDMO Services Product

Table 167. WuXi ATU Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 168. WuXi ATU Recent Development

Table 169. Ubrigene Company Details

Table 170. Ubrigene Business Overview

Table 171. Ubrigene Viral Vector CDMO Services Product

Table 172. Ubrigene Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 173. Ubrigene Recent Development

Table 174. Porton Biologics Company Details

Table 175. Porton Biologics Business Overview

Table 176. Porton Biologics Viral Vector CDMO Services Product

Table 177. Porton Biologics Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 178. Porton Biologics Recent Development

Table 179. Pharmaron Company Details

Table 180. Pharmaron Business Overview

Table 181. Pharmaron Viral Vector CDMO Services Product

Table 182. Pharmaron Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 183. Pharmaron Recent Development

Table 184. PackGene Biotechnology Company Details

Table 185. PackGene Biotechnology Business Overview

Table 186. PackGene Biotechnology Viral Vector CDMO Services Product

Table 187. PackGene Biotechnology Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 188. PackGene Biotechnology Recent Development

Table 189. Hillgene Company Details

Table 190. Hillgene Business Overview

Table 191. Hillgene Viral Vector CDMO Services Product

Table 192. Hillgene Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 193. Hillgene Recent Development

Table 194. Asymchem Company Details

Table 195. Asymchem Business Overview

Table 196. Asymchem Viral Vector CDMO Services Product

Table 197. Asymchem Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 198. Asymchem Recent Development

Table 199. Exthera Company Details

Table 200. Exthera Business Overview

Table 201. Exthera Viral Vector CDMO Services Product

Table 202. Exthera Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 203. Exthera Recent Development

Table 204. Flash Therapeutics Company Details

Table 205. Flash Therapeutics Business Overview

Table 206. Flash Therapeutics Viral Vector CDMO Services Product

Table 207. Flash Therapeutics Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 208. Flash Therapeutics Recent Development

Table 209. VIVEBiotech Company Details

Table 210. VIVEBiotech Business Overview

Table 211. VIVEBiotech Viral Vector CDMO Services Product

Table 212. VIVEBiotech Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 213. VIVEBiotech Recent Development

Table 214. FinVector Company Details

Table 215. FinVector Business Overview

Table 216. FinVector Viral Vector CDMO Services Product

Table 217. FinVector Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 218. FinVector Recent Development

Table 219. uBriGene Company Details

Table 220. uBriGene Business Overview

Table 221. uBriGene Viral Vector CDMO Services Product

Table 222. uBriGene Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 223. uBriGene Recent Development

Table 224. Eurogentec Company Details

Table 225. Eurogentec Business Overview

Table 226. Eurogentec Viral Vector CDMO Services Product

Table 227. Eurogentec Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 228. Eurogentec Recent Development

Table 229. VGXI Company Details

Table 230. VGXI Business Overview

Table 231. VGXI Viral Vector CDMO Services Product

Table 232. VGXI Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)

Table 233. VGXI Recent Development

Table 234. Research Programs/Design for This Report

Table 235. Key Data Information from Secondary Sources

Table 236. Key Data Information from Primary Sources

Table 237. Authors List of This Report

List of Figures

Figure 1. Viral Vector CDMO Services Picture

Figure 2. Global Viral Vector CDMO Services Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Viral Vector CDMO Services Market Share by Type: 2024 VS 2031

Figure 4. AAV Features

Figure 5. Lentivirus Features

Figure 6. Adenovirus Features

Figure 7. HSV Features

Figure 8. Others Features

Figure 9. Global Viral Vector CDMO Services Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Viral Vector CDMO Services Market Share by Application: 2024 VS 2031

Figure 11. Vaccine Development Case Studies

Figure 12. Gene Therapy Case Studies

Figure 13. Academic Scientific Research Institution Case Studies

Figure 14. Others Case Studies

Figure 15. Viral Vector CDMO Services Report Years Considered

Figure 16. Global Viral Vector CDMO Services Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Viral Vector CDMO Services Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Viral Vector CDMO Services Market Share by Region: 2024 VS 2031

Figure 19. Global Viral Vector CDMO Services Market Share by Players in 2024

Figure 20. Global Top Viral Vector CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector CDMO Services as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Viral Vector CDMO Services Revenue in 2024

Figure 22. North America Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Viral Vector CDMO Services Market Share by Country (2020-2031)

Figure 24. United States Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Viral Vector CDMO Services Market Share by Country (2020-2031)

Figure 28. Germany Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Viral Vector CDMO Services Market Share by Region (2020-2031)

Figure 36. China Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Viral Vector CDMO Services Market Share by Country (2020-2031)

Figure 44. Mexico Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Viral Vector CDMO Services Market Share by Country (2020-2031)

Figure 48. Turkey Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 52. Lonza Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 53. Catalent Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 54. Charles River Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 55. Merck Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 56. SK pharmteco Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 57. Oxford Biomedica Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 58. AGC Biologics（MolMed） Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 59. Gene Universal Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 60. Polyplus (Sartorius) Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 61. CCRM Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 62. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 63. Biovian Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 64. Miltenyi Bioindustry Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 65. Aldevron Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 66. Takara Bio Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 67. Yposkesi Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 68. Genezen Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 69. GenScript ProBio Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 70. EurekaBio Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 71. Obio Technology Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 72. GeneSail Biotech Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 73. VectorBuilder Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 74. WuXi ATU Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 75. Ubrigene Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 76. Porton Biologics Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 77. Pharmaron Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 78. PackGene Biotechnology Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 79. Hillgene Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 80. Asymchem Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 81. Exthera Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 82. Flash Therapeutics Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 83. VIVEBiotech Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 84. FinVector Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 85. uBriGene Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 86. Eurogentec Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 87. VGXI Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Viral Vector CDMO Services Market Research Report 2025

Published Date: 2025-05-06

Report Code: QYRE-Auto-18U16299

Global Viral Vector CDMO Services Market Research Report 2025

FEATURED COMPANIES

Viral Vector CDMO Services Market

Scope of Viral Vector CDMO Services Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Viral Vector CDMO Services Market report?

What are the Application segmentation covered in the Viral Vector CDMO Services Market report?

What are the Type segmentation covered in the Viral Vector CDMO Services Market report?

FEATURED COMPANIES